PT1812581E - Processo de preparação de β¿lactamas opticamente activas protegidas por n-carbamato através de resolução óptica empregando uma lipase de candida antarctica - Google Patents

Processo de preparação de β¿lactamas opticamente activas protegidas por n-carbamato através de resolução óptica empregando uma lipase de candida antarctica Download PDF

Info

Publication number
PT1812581E
PT1812581E PT05826088T PT05826088T PT1812581E PT 1812581 E PT1812581 E PT 1812581E PT 05826088 T PT05826088 T PT 05826088T PT 05826088 T PT05826088 T PT 05826088T PT 1812581 E PT1812581 E PT 1812581E
Authority
PT
Portugal
Prior art keywords
lactams
candida antarctica
preparation
optically active
optical resolution
Prior art date
Application number
PT05826088T
Other languages
English (en)
Portuguese (pt)
Inventor
Ankush Argade
Original Assignee
Rigel Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rigel Pharmaceuticals Inc filed Critical Rigel Pharmaceuticals Inc
Publication of PT1812581E publication Critical patent/PT1812581E/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/10Nitrogen as only ring hetero atom
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00Preparation of nitrogen-containing organic compounds
    • C12P13/04Alpha- or beta- amino acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P41/00Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
    • C12P41/006Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by reactions involving C-N bonds, e.g. nitriles, amides, hydantoins, carbamates, lactames, transamination reactions, or keto group formation from racemic mixtures
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PT05826088T 2004-11-15 2005-11-15 Processo de preparação de β¿lactamas opticamente activas protegidas por n-carbamato através de resolução óptica empregando uma lipase de candida antarctica PT1812581E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US62840104P 2004-11-15 2004-11-15

Publications (1)

Publication Number Publication Date
PT1812581E true PT1812581E (pt) 2009-04-22

Family

ID=36190809

Family Applications (1)

Application Number Title Priority Date Filing Date
PT05826088T PT1812581E (pt) 2004-11-15 2005-11-15 Processo de preparação de β¿lactamas opticamente activas protegidas por n-carbamato através de resolução óptica empregando uma lipase de candida antarctica

Country Status (10)

Country Link
US (1) US7459301B2 (https=)
EP (1) EP1812581B1 (https=)
JP (1) JP4738416B2 (https=)
AT (1) ATE421996T1 (https=)
CA (1) CA2580151C (https=)
DE (1) DE602005012597D1 (https=)
DK (1) DK1812581T3 (https=)
ES (1) ES2320364T3 (https=)
PT (1) PT1812581E (https=)
WO (1) WO2006055528A2 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7754714B2 (en) * 2004-05-18 2010-07-13 Rigel Pharmaceuticals, Inc. Cycloalkyl substituted pyrimidinediamine compounds and their uses
GB2420559B (en) * 2004-11-15 2008-08-06 Rigel Pharmaceuticals Inc Stereoisomerically enriched 3-aminocarbonyl bicycloheptene pyrimidinediamine compounds and their uses
WO2007070872A1 (en) 2005-12-15 2007-06-21 Rigel Pharmaceuticals, Inc. Kinase inhibitors and their uses
HU227663B1 (en) * 2007-07-09 2011-10-28 Univ Szegedi Resolution process
RU2535032C2 (ru) 2008-12-22 2014-12-10 Милленниум Фармасьютикалз, Инк. Сочетание ингибиторов аврора киназы и анти-cd 20 антител
EP2489663A1 (en) 2011-02-16 2012-08-22 Almirall, S.A. Compounds as syk kinase inhibitors
EP3076963A4 (en) 2013-12-06 2017-09-13 Millennium Pharmaceuticals, Inc. Combination of aurora kinase inhibitors and anti-cd30 antibodies
WO2017015316A1 (en) 2015-07-21 2017-01-26 Millennium Pharmaceuticals, Inc. Administration of aurora kinase inhibitor and chemotherapeutic agents
WO2019195658A1 (en) 2018-04-05 2019-10-10 Dana-Farber Cancer Institute, Inc. Sting levels as a biomarker for cancer immunotherapy
CN111194304B (zh) * 2018-04-18 2022-09-27 宜昌东阳光长江药业股份有限公司 一种桥环化合物的制备方法
US20220305048A1 (en) 2019-08-26 2022-09-29 Dana-Farber Cancer Institute, Inc. Use of heparin to promote type 1 interferon signaling

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE258605T1 (de) 1998-07-09 2004-02-15 Lonza Ag Verfahren zur herstellung von (1r,4s)-2- azabicyclo 2.2.1 hept-5-en-3-on-derivaten

Also Published As

Publication number Publication date
DE602005012597D1 (de) 2009-03-19
DK1812581T3 (da) 2009-05-11
EP1812581A2 (en) 2007-08-01
WO2006055528A3 (en) 2006-08-31
WO2006055528A2 (en) 2006-05-26
JP4738416B2 (ja) 2011-08-03
EP1812581B1 (en) 2009-01-28
CA2580151A1 (en) 2006-05-26
ES2320364T3 (es) 2009-05-21
US7459301B2 (en) 2008-12-02
CA2580151C (en) 2014-02-04
JP2008520206A (ja) 2008-06-19
ATE421996T1 (de) 2009-02-15
US20060166308A1 (en) 2006-07-27

Similar Documents

Publication Publication Date Title
Margolin Enzymes in the synthesis of chiral drugs
Bezborodov et al. Enzymatic biocatalysis in chemical synthesis of pharmaceuticals
Patel Biocatalytic synthesis of intermediates for the synthesis of chiral drug substances
PT1812581E (pt) Processo de preparação de β¿lactamas opticamente activas protegidas por n-carbamato através de resolução óptica empregando uma lipase de candida antarctica
Gotor Biocatalysis applied to the preparation of pharmaceuticals
Gotor Non-conventional hydrolase chemistry: amide and carbamate bond formation catalyzed by lipases
Miyazawa Enzymatic resolution of amino acids via ester hydrolysis
WO2006133079A3 (en) Increasing perhydrolase activity in esterases and/or lipases
ATE417100T1 (de) Eine verbesserte immobilisierte penicillin g acylase
Assaf et al. Scope, limitations and classification of lactamases
Sergeeva et al. Lipase-catalyzed transamidation of non-activated amides in organic solvent
DE69914458D1 (de) Verfahren zur enzymatischen auflösung von laktamen
Gill et al. Biocatalytic ammonolysis of (5S)-4, 5-dihydro-1H-pyrrole-1, 5-dicarboxylic acid, 1-(1, 1-dimethylethyl)-5-ethyl ester: Preparation of an intermediate to the dipeptidyl peptidase IV inhibitor Saxagliptin
DK0649907T3 (da) Enzymatisk hydroxyleringsproces til fremstilling af HMG-CoA-reduktaseinhibitorer og mellemprodukter derfor
PT904348E (pt) Processo para a producao de aminoalcoois e seus derivados
AU2002316575A1 (en) Microorganisms and processes for enhanced production of pantothenate
Simons et al. Enzyme-catalysed deprotection of N-acetyl and N-formyl amino acids
EP1745137A1 (en) Enzymatic preparation of an enantiomerically enriched beta-2-amino acids
EP1559789A8 (en) Method for producing dipeptide
DK0602740T3 (da) Fremgangsmåde til enzymatisk fremstilling af optisk aktive transglycidsyreestere
Patel Biocatalytic routes to chiral intermediates for development of drugs
WO2003066871A3 (en) Compositions and methods for altering biosynthesis of taxanes and taxane-related compounds
US7125692B2 (en) Process for producing monomer
AR087317A1 (es) UN PROCESO PARA LA PRODUCCION ENZIMATICA DE CARNITINA A PARTIR DE b-LACTONAS
Chu et al. Enzymes for the removal of N-carbobenzyloxy protecting groups from N-carbobenzyloxy-D-and L-amino acids